D.C. Circuit Court Remands FOIA Suit Over ID Of Supplier Of Execution Drug

Mealey's (February 14, 2023, 4:12 PM EST) -- WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals has reversed a district court finding that the identity of the company that supplies the U.S. Bureau of Prisons with pentobarbital is exempt from disclosure under the Freedom of Information Act (FOIA) and remanded the case....